Brendan McQuillan

Brendan McQuillan is a Professor and Dean (Global MD) at the UWA Medical School, specializing in Internal Medicine. He holds a dual role as a Cardiologist at Sir Charles Gairdner Hospital, serving as Director of Echocardiography and former Director of Clinical Training. His academic journey includes a PhD in vascular biology from the Heart Research Institute of WA, postdoctoral research at Harvard University, and a Fellowship in Echocardiography at Massachusetts General Hospital.

Research interests span cardiovascular disease, atherosclerosis, echocardiography, and clinical trials. He leads projects funded by NHMRC and the National Heart Foundation, including studies on obstructive sleep apnea's impact on cardiovascular outcomes and novel anticoagulant therapies. Notable roles include principal investigator for VICTORIA and CLEAR-Outcomes trials and membership in the Data Safety Monitoring Board for LoDoCo2 and LoDoCo MI trials.

Academically, he supervises advanced cardiology trainees and actively participates in medical education. Awards include RACP and UWA Research Fellowships. He contributes to professional societies such as the Cardiac Society of Australia and New Zealand, where he chairs committees and organizes conferences. Ongoing collaborations focus on integrating machine learning for risk stratification in atrial fibrillation and optimizing care for rural populations.

Key achievements include improving door-to-balloon times in STEMI patients and advancing understanding of cardiovascular risks in nonalcoholic fatty liver disease. His work aligns with UN Sustainable Development Goals promoting health equity and reducing non-communicable diseases.